Item Type | Name |
Concept
|
Estrogen Antagonists
|
Concept
|
Estrogens
|
Concept
|
Receptors, Estrogen
|
Concept
|
Estrogen Receptor beta
|
Concept
|
Estrogen Replacement Therapy
|
Concept
|
Estrogen Receptor alpha
|
Academic Article
|
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.
|
Academic Article
|
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
|
Academic Article
|
Predisposition testing for inherited breast cancer.
|
Academic Article
|
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
|
Academic Article
|
Parity and breastfeeding are protective against breast cancer in Nigerian women.
|
Academic Article
|
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.
|
Academic Article
|
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
|
Academic Article
|
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.
|
Academic Article
|
Estrogen deprivation therapy and colon cancer risk in breast cancer patients.
|
Academic Article
|
Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
|
Academic Article
|
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.
|
Academic Article
|
Glucocorticoid receptor expression in breast cancer associates with older patient age.
|
Academic Article
|
Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?
|
Academic Article
|
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.
|
Academic Article
|
Concordance in histological and biological parameters between first and second primary breast cancers.
|
Academic Article
|
Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
|
Academic Article
|
A comparison of bilateral breast cancers in BRCA carriers.
|
Academic Article
|
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
|
Academic Article
|
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
|
Academic Article
|
Clinical implications of ERß methylation on sporadic breast cancers in Chinese women.
|
Academic Article
|
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.
|
Academic Article
|
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
|
Academic Article
|
Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.
|
Academic Article
|
Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
|
Academic Article
|
Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers.
|
Academic Article
|
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
|
Academic Article
|
A comprehensive examination of breast cancer risk loci in African American women.
|
Academic Article
|
Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution.
|
Academic Article
|
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
|
Academic Article
|
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
|
Academic Article
|
Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain.
|
Academic Article
|
Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.
|
Academic Article
|
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
|
Academic Article
|
Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
|
Academic Article
|
Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry.
|
Academic Article
|
Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.
|
Academic Article
|
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
|
Academic Article
|
Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy?
|
Academic Article
|
Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry.
|
Academic Article
|
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
|
Academic Article
|
Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
|
Academic Article
|
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
|
Academic Article
|
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer.
|
Academic Article
|
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.
|